Niemann-Pick C1-like 1 mediates α-tocopherol transport

Molecular Pharmacology

Volumn 74, Issue 1, 2008, Pages 42-49

  Narushima, Kazuya ^a   Takada, Tappei ^a   Yamanashi, Yoshihide ^a   Suzuki, Hiroshi ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; CYCLOSPORIN A; EZETIMIBE; MEMBRANE PROTEIN; NIEMANN PICK C1 LIKE 1 PROTEIN; RETINOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DRUG ABSORPTION; DRUG EFFECT; DRUG TARGETING; DRUG UPTAKE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTESTINE ABSORPTION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ALPHA-TOCOPHEROL; ANIMALS; ANTICHOLESTEREMIC AGENTS; AZETIDINES; BIOLOGICAL TRANSPORT; CACO-2 CELLS; CHOLESTEROL; CYCLOSPORINE; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL ABSORPTION; MALE; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; MICELLES; PHOSPHATIDYLCHOLINES; RATS; RATS, WISTAR; TAUROCHOLIC ACID; TEMPERATURE; TIME FACTORS; VITAMIN A;

EID: 45749155204     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.107.043034     Document Type: Article

References (28)

1. Altmann SW, Davis HR, Jr., Zhu LJ, Yao X, Hoos LM, Tetzloff G, Iyer SP, Maguire M, Golovko A, Zeng M, Wang L, Murgolo N, and Graziano MP (2004) Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science 303:1201-1204.
2. Anwar K, Iqbal J, and Hussain MM (2007) Mechanisms involved in vitamin E transport by primary enterocytes and in vivo absorption. J Lipid Res 48:2028-2038.
3. Bergman AJ, Burke J, Larson P, Johnson-Levonas AO, Reyderman L, Statkevich P, Kosoglou T, Greenberg HE, Kraft WK, Frick G, et al. (2006) Effects of ezetimibe on cyclosporine pharmacokinetics in healthy subjects. J Clin Pharmacol 46:321-327.
4. Bodo A, Bakos E, Szeri F, Varadi A, and Sarkadi B (2003) Differential modulation of the human liver conjugate transporters MRP2 and MRP3 by bile acids and organic anions. J Biol Chem 278:23529-23537.
5. Cohen JC, Pertsemlidis A, Fahmi S, Esmail S, Vega GL, Grundy SM, and Hobbs HH (2006) Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels. Proc Natl Acad Sci U S A 103:1810-1815.
6. Davies JP, Scott C, Oishi K, Liapis A, and Ioannou YA (2005) Inactivation of NPC1L1 causes multiple lipid transport defects and protects against diet-induced hypercholesterolemia. J Biol Chem 280:12710-12720.
7. Davis HR, Jr., Zhu LJ, Hoos LM, Tetzloff G, Maguire M, Liu J, Yao X, Iyer SP, Lam MH, et al. (2004) Niemann-Pick C1 Like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis. J Biol Chem 279:33586-33592.
8. Garcia-Calvo M, Lisnock J, Bull HG, Hawes BE, Burnett DA, Braun MP, Crona JH, Davis HR, Jr., Dean DC, et al. (2005) The target of ezetimibe is Niemann-Pick C1-like 1 (NPC1L1). Proc Natl Acad Sci U S A 102:8132-8137.
9. Hacquebard M and Carpentier YA (2005) Vitamin E: absorption, plasma transport and cell uptake. Curr Opin Clin Nutr Metab Care 8:133-138.
10. Hawes BE, O'Neill KA, Yao X, Crona JH, Davis HR, Jr., Graziano MP, and Altmann SW (2007) In vivo responsiveness to ezetimibe correlates with Niemann-Pick C1 like-1 (NPC1L1) binding affinity: Comparison of multiple species NPC1L1 orthologs. Mol Pharmacol 71:19-29.
11. Hawk CT and Leary SL (1995) Formulary for Laboratory Animals, p 74, Iowa State University Press, Ames, IA.
12. Ito K, Koresawa T, Nakano K, and Horie T (2004) Mrp2 is involved in benzylpenicillin-induced choleresis. Am J Physiol Gastrointest Liver Physiol 287:G42-G49.
13. Kaempf-Rotzoll DE, Traber MG, and Arai H (2003) Vitamin E and transfer proteins. Curr Opin Lipidol 14:249-254.
14. Knopp RH, Gitter H, Truitt T, Bays H, Manion CV, Lipka LJ, LeBeaut AP, Suresh R, Yang B, and Veltri EP (2003) Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia. Eur Heart J 24:729-741.
15. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
16. Oram JF, Vaughan AM, and Stocker R (2001) ATP-binding cassette transporter A1 mediates cellular secretion of alpha-tocopherol. J Biol Chem 276:39898-39902.
17. Patel J, Sheehan V, and Gurk-Turner C (2003) Ezetimibe (Zetia): a new type of lipid-lowering agent. Proc (Bayl Univ Med Cent) 16:354-358.
18. Reboul E, Klein A, Bietrix F, Gleize B, Malezet-Desmoulins C, Schneider M, Margotat A, Lagrost L, Collet X, and Borel P (2006) Scavenger receptor class B type I (SR-BI) is involved in vitamin E transport across the enterocyte. J Biol Chem 281:4739-4745.
19. Rigotti A (2007) Absorption, transport, and tissue delivery of vitamin E. Mol Aspects Med 28:423-436.
20. Sané AT, Sinnett D, Delvin E, Bendayan M, Marcil V, Menard D, Beaulieu JF, and Levy E (2006) Localization and role of NPC1L1 in cholesterol absorption in human intestine. J Lipid Res 47:2112-2120.
21. Temel RE, Tang W, Ma Y, Rudel LL, Willingham MC, Ioannou YA, Davies JP, Nilsson LM, and Yu L (2007) Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe. J Clin Invest 117:1968-1978.
22. Treiber A, Schneiter R, Hausler S, and Stieger B (2007) Bosentan is a substrate of human OATP1B1 and OATP1B3: inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafil. Drug Metab Dispos 35:1400-1407.
23. Tso P, Balint JA, and Rodgers JB (1980) Effect of hydrophobic surfactant (Pluronic L-81) on lymphatic lipid transport in the rat. Am J Physiol 239:G348-G353.
24. van Heek M, Farley C, Compton DS, Hoos L, Alton KB, Sybertz EJ, and Davis HR Jr (2000) Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663. Br J Pharmacol 129:1748-1754.
25. van Heek M, Farley C, Compton DS, Hoos L, and Davis HR (2001) Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function. Br J Pharmacol 134:409-417.
26. Yamamoto T, Ito K, Honma M, Takada T, and Suzuki H (2007) Cholesterol-lowering effect of ezetimibe in uridine diphosphate glucuronosyltransferase 1A-deficient (Gunn) rats. Drug Metab Dispos 35:1455-1458.
27. Yamanashi Y, Takada T, and Suzuki H (2007) Niemann-Pick C1-like 1 overexpression facilitates ezetimibe-sensitive cholesterol and β-sitosterol uptake in CaCo-2 cells. J Pharmacol Exp Ther 320:559-564.
28. Zelcer N, Huisman MT, Reid G, Wielinga P, Breedveld P, Kuil A, Knipscheer P, Schellens JH, Schinkel AH, and Borst P (2003) Evidence for two interacting ligand binding sites in human multidrug resistance protein 2 (ATP binding cassette C2). J Biol Chem 278:23538-23544.